Harvard Bioscience Inc (HBIO)

개요 뉴스 가격 이력 Financials 토론 예측 주식 분할

Relative Volume:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1051)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

최신 SEC 제출 서류

HBIO's Discussions on Twitter

Compare HBIO vs ISRG, BDX, RMD, MDLN, ALC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
HBIO Harvard Bioscience Inc	8.24	37.51M	85.53M	-9.78M	1.28M	-2.1952
ISRG Intuitive Surgical Inc	427.64	151.08B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	188.89	51.45B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	234.60	32.99B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.76	31.37B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	64.35	31.11B	10.63B	819.00M	1.59B	1.6577

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-04-09	다운그레이드	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	업그레이드	The Benchmark Company	Speculative Buy → Buy
2021-01-07	업그레이드	The Benchmark Company	Speculative Buy → Buy
2020-12-09	개시	Northland Capital	Outperform
2020-11-10	개시	KeyBanc Capital Markets	Overweight
2019-07-08	다운그레이드	Janney	Buy → Neutral
2018-01-24	재확인	Janney	Buy
2018-01-23	재확인	The Benchmark Company	Buy
2016-11-17	개시	Singular Research	Buy
2015-07-28	개시	The Benchmark Company	Buy

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience Inc (HBIO) 재무 분석

Harvard Bioscience Inc 주식 (HBIO) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
DENELSKY STEPHEN J	Director	Mar 17 '26	Buy	4.87	10,000	48,700	21,000
Snider William	Director	Mar 17 '26	Buy	4.85	8,475	41,104	32,000
Snider William	Director	Mar 16 '26	Buy	4.99	12,525	62,500	23,525
Duke John D	Chief Executive Officer	Mar 16 '26	Buy	5.01	5,000	25,050	105,000

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

Compare HBIO vs ISRG, BDX, RMD, MDLN, ALC

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience creates scientific advisory board - Investing.com

Harvard Bioscience forms scientific advisory board with four members - StreetInsider

Harvard Bioscience Announces Creation Of Scientific Advisory Board - TradingView

Harvard Bioscience Announces Creation of Scientific Advisory Board - GlobeNewswire

Harvard Bioscience, Inc. Announces Creation of Scientific Advisory Board - www.marketscreener.com

Harvard Bioscience stock gained 1.92 percent on October 5, 2026 - AD HOC NEWS

Harvard Bioscience grows revenue 11.10 percent: what it means for Harvard Bioscience stock - AD HOC NEWS

North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.

Harvard Bioscience stock holds at USD 7.92 after reverse split - AD HOC NEWS

Over 5% stake disclosed in Harvard Bioscience (HBIO) - Stock Titan

Harvard Bioscience stock trades steady as investors look to latest revenue trends - ad-hoc-news.de

Harvard (HBIO) Chart: Records a 0.13% Increase to $7.49; Price Context: the Price Remains Bounded by the Supplied Support and Resistance on the DayVolatility Surface - vinanet.vn

Harvard Bioscience Insider Confidence Rewarded, Stock Hits US$32m Market Cap - Sahm

Harvard Bioscience Insider Confidence Rewarded, Stock Hits US$32m Market Cap - simplywall.st

Harvard (HBIO) Results Review: EPS Exceeds Its Estimate in the Current Update; Session Move: The Stock Gains 1.58% at the CloseNet Profit Margin - vinanet.vn

Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript - The Globe and Mail

Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript - AOL.ca

Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com South Africa

HBIO Maintained by Benchmark -- Price Target Raised to $7.50 - GuruFocus

Benchmark raises Harvard Bioscience stock price target on revenue beat - Investing.com

Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com India

Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com UK

Benchmark raises Harvard Bioscience stock price target on revenue beat - Investing.com

Harvard Bioscience, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HBIO) 2026-08-12 - Seeking Alpha

Harvard Bioscience, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

HARVARD BIOSCIENCE INC 2026: Revenue $22.73M, EPS ($0.64) — 10-Q Summary - TradingView

Harvard Bioscience (NASDAQ: HBIO) grows Q2 sales but faces higher debt costs - Stock Titan

Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights - GuruFocus

HBIO Looks 66.8% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus

Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ... - Yahoo Finance

Harvard Bioscience Releases Q2 2026 Financial Results - AlphaStreet

Earnings call transcript: Harvard Bioscience tops Q2 2026 forecasts, raises outlook - Investing.com Nigeria

HBio Q2 2026 slides: revenue up 11%, China growth drives guidance raise - Investing.com Nigeria

Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance - Yahoo Finance

Harvard Bioscience Raises Full-Year 2026 Revenue Guidance After Strong Second-Quarter Growth - Minichart

Earnings call transcript: Harvard Bioscience tops Q2 2026 forecasts, raises outlook - Investing.com

Why is Harvard Bioscience stock gaining today? By Investing.com - Investing.com Canada

Is Harvard Bioscience Inc (HBIO) Undervalued After Q2 Earnings B - GuruFocus

Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com South Africa

Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com Australia

Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com Canada

Harvard Bioscience beats estimates, raises 2026 guidance - Investing.com

Harvard Bioscience beats estimates, raises 2026 guidance - Investing.com

Harvard Bioscience Announces Second Quarter 2026 Financial Results - The Manila Times

Harvard Bioscience: Q2 Earnings Snapshot - marketscreener.com

Harvard Bioscience: Q2 Earnings Snapshot - AOL.com

Harvard Bioscience: Q2 Earnings Snapshot - KTVB

Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook - TradingView

Harvard Bioscience Q2 Revenue Rises 11 Percent to $22.7 Million - Quiver Quantitative

Harvard Bioscience Announces Second Quarter 2026 Financial Results - marketscreener.com

Harvard Bioscience Inc (HBIO) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Harvard Bioscience Inc 주식 (HBIO) 내부자 거래

HBIO과 유사한 종목